Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | FAAH | O00519 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8214063 | 1.00 | ALDH1A1 (0.31) | ALDH1A1TDP1KDM4EMEN1POLB | |
| SCHEMBL74357 | 0.83 | GRIK1 (0.31) | KDM4EMEN1POLBMAPTKMT2A | |
| SCHEMBL74358 | 0.83 | GRIK1 (0.31) | KDM4EMEN1POLBMAPTKMT2A | |
| SCHEMBL554945 | 0.81 | KDM4E (0.33) | TDP1KDM4E | |
| SCHEMBL554943 | 0.81 | KDM4E (0.33) | TDP1KDM4E | |
| SCHEMBL1786546 | 0.81 | CHRM1 (0.36) | TDP1POLBKMT2ATSHRFAAH | |
| SCHEMBL811456 | 0.81 | ALDH1A1 (0.33) | ALDH1A1TDP1 | |
| SCHEMBL811457 | 0.81 | ALDH1A1 (0.33) | ALDH1A1TDP1 | |
| SCHEMBL27805093 | 0.81 | GRIK1 (0.31) | — | |
| SCHEMBL1786543 | 0.81 | CHRM1 (0.36) | TDP1POLBKMT2ATSHRFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130065969-A9 | Odour Compounds | GIVAUDAN SA (CH) | 2013-03-14 | — | — | US | disclosed |
| US-20120184630-A1 | Odour Compounds | KRAFT PHILIP (CH) | 2012-07-19 | — | — | US | disclosed |
| EP-2475639-A2 | ODOUR COMPOUNDS | Givaudan SA (CH) | 2012-07-18 | — | — | EP | disclosed |
| WO-2011029895-A2 | ODOUR COMPOUNDS | GIVAUDAN SA (CH) | 2011-03-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130065969-A9 | Odour Compounds | PRMT9, PRMT5, PRMT1 | ALDH1A1 2749/4885TDP1 4605/4885KDM4E 434/4885 |
| US-20120184630-A1 | Odour Compounds | PRMT9, PRMT5, PRMT1 | ALDH1A1 2749/4885TDP1 4605/4885KDM4E 434/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.